ACETAZOLAMIDE SODIUM (acetazolamide) by Hikma is clinical pharmacology acetazolamide for injection is a potent carbonic anhydrase inhibitor, effective in the control of fluid secretion (e. Approved for heart failure, glaucoma. First approved in 1995.
Drug data last refreshed 20h ago
CLINICAL PHARMACOLOGY Acetazolamide for Injection is a potent carbonic anhydrase inhibitor, effective in the control of fluid secretion (e.g., some types of glaucoma), in the treatment of certain convulsive disorders (e.g., epilepsy) and in the promotion of diuresis in instances of abnormal fluid…
Worked on ACETAZOLAMIDE SODIUM at Hikma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep Apnea
HighCycle: Effect of Acetazolamide on Pulmonary Artery Pressure in Women Compared to Men
HighCycle Study: Effect of Acetazolamide on Sleep Disordered Breathing in Women Compared to Men
HighCycle Study: Effect of Acetazolamide on Acute Mountain Sickness in Women Compared to Men
Acetazolamide and Exercise Performance at Altitude